Global Liposome Drug Delivery Market Data Survey Report 2025
Summary
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
The global Liposome Drug Delivery market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Major Type
as follows:
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
The global Liposome Drug Delivery market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
- Johnson & Johnson
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Luye Pharma
- Sigma-Tau Group
- Sigma-Tau Group
- Ipsen (Onivyde)
- Fudan-Zhangjiang
- CSPC
- Novartis
- Kingond Pharm
- Shanghai New Asia
- Spectrum Pharmaceuticals
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
Major Type
as follows:
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Liposomal Bupivacaine
- Other Liposomals
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Johnson & Johnson
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Gilead Sciences
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Pacira
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sun Pharmaceutical
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Luye Pharma
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Sigma-Tau Group
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sigma-Tau Group
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Ipsen (Onivyde)
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Fudan-Zhangjiang
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 CSPC
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Novartis
3.12 Kingond Pharm
3.13 Shanghai New Asia
3.14 Spectrum Pharmaceuticals
4 MAJOR APPLICATION
4.1 Fungal Infection Therapy
4.1.1 Overview
4.1.2 Fungal Infection Therapy Market Size and Forecast
4.2 Cancer & Tumor Therapy
4.2.1 Overview
4.2.2 Cancer & Tumor Therapy Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET BY TYPE
5.1 Liposomal Doxorubicin
5.1.1 Overview
5.1.2 Liposomal Doxorubicin Market Size and Forecast
5.2 Liposomal Amphoteracin B
5.2.1 Overview
5.2.2 Liposomal Amphoteracin B Market Size and Forecast
5.3 Liposomal Paclitaxel
5.3.1 Overview
5.3.2 Liposomal Paclitaxel Market Size and Forecast
5.4 Liposomal Bupivacaine
5.4.1 Overview
5.4.2 Liposomal Bupivacaine Market Size and Forecast
5.5 Other Liposomals
5.5.1 Overview
5.5.2 Other Liposomals Market Size and Forecast
5.6 Other Liposomals
5.6.1 Overview
5.6.2 Other Liposomals Market Size and Forecast
6 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Johnson & Johnson
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Gilead Sciences
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Pacira
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sun Pharmaceutical
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Luye Pharma
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Sigma-Tau Group
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sigma-Tau Group
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Ipsen (Onivyde)
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Fudan-Zhangjiang
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 CSPC
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Novartis
3.12 Kingond Pharm
3.13 Shanghai New Asia
3.14 Spectrum Pharmaceuticals
4 MAJOR APPLICATION
4.1 Fungal Infection Therapy
4.1.1 Overview
4.1.2 Fungal Infection Therapy Market Size and Forecast
4.2 Cancer & Tumor Therapy
4.2.1 Overview
4.2.2 Cancer & Tumor Therapy Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET BY TYPE
5.1 Liposomal Doxorubicin
5.1.1 Overview
5.1.2 Liposomal Doxorubicin Market Size and Forecast
5.2 Liposomal Amphoteracin B
5.2.1 Overview
5.2.2 Liposomal Amphoteracin B Market Size and Forecast
5.3 Liposomal Paclitaxel
5.3.1 Overview
5.3.2 Liposomal Paclitaxel Market Size and Forecast
5.4 Liposomal Bupivacaine
5.4.1 Overview
5.4.2 Liposomal Bupivacaine Market Size and Forecast
5.5 Other Liposomals
5.5.1 Overview
5.5.2 Other Liposomals Market Size and Forecast
5.6 Other Liposomals
5.6.1 Overview
5.6.2 Other Liposomals Market Size and Forecast
6 CONCLUSION
LIST OF TABLES
Tab REGIONAL PRODUCTION 2011-2017 (MILLION USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Tab Sales Revenue, Volume, Price, Cost and Margin of Gilead Sciences
Tab Sales Revenue, Volume, Price, Cost and Margin of Pacira
Tab Sales Revenue, Volume, Price, Cost and Margin of Sun Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Luye Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Sigma-Tau Group
Tab Sales Revenue, Volume, Price, Cost and Margin of Sigma-Tau Group
Tab Sales Revenue, Volume, Price, Cost and Margin of Ipsen (Onivyde)
Tab Sales Revenue, Volume, Price, Cost and Margin of Fudan-Zhangjiang
Tab Sales Revenue, Volume, Price, Cost and Margin of CSPC
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis
Tab Sales Revenue, Volume, Price, Cost and Margin of Kingond Pharm
Tab Sales Revenue, Volume, Price, Cost and Margin of Shanghai New Asia
Tab Sales Revenue, Volume, Price, Cost and Margin of Spectrum Pharmaceuticals
Tab REGIONAL PRODUCTION 2011-2017 (MILLION USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Tab Sales Revenue, Volume, Price, Cost and Margin of Gilead Sciences
Tab Sales Revenue, Volume, Price, Cost and Margin of Pacira
Tab Sales Revenue, Volume, Price, Cost and Margin of Sun Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Luye Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Sigma-Tau Group
Tab Sales Revenue, Volume, Price, Cost and Margin of Sigma-Tau Group
Tab Sales Revenue, Volume, Price, Cost and Margin of Ipsen (Onivyde)
Tab Sales Revenue, Volume, Price, Cost and Margin of Fudan-Zhangjiang
Tab Sales Revenue, Volume, Price, Cost and Margin of CSPC
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis
Tab Sales Revenue, Volume, Price, Cost and Margin of Kingond Pharm
Tab Sales Revenue, Volume, Price, Cost and Margin of Shanghai New Asia
Tab Sales Revenue, Volume, Price, Cost and Margin of Spectrum Pharmaceuticals
LIST OF FIGURES
Fig Global Liposome Drug Delivery Market Size and CAGR 2011-2017 (Million USD)
Fig Global Liposome Drug Delivery Market Size and CAGR 2011-2017 (Volume)
Fig Global Liposome Drug Delivery Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Liposome Drug Delivery Market Forecast and CAGR 2018-2025 (Volume)
Fig Fungal Infection Therapy Market Size and CAGR 2011-2017 (Million USD)
Fig Fungal Infection Therapy Market Size and CAGR 2011-2017 (Volume)
Fig Fungal Infection Therapy Market Forecast and CAGR 2018-2025 (Million USD)
Fig Fungal Infection Therapy Market Forecast and CAGR 2018-2025 (Volume)
Fig Cancer & Tumor Therapy Market Size and CAGR 2011-2017 (Million USD)
Fig Cancer & Tumor Therapy Market Size and CAGR 2011-2017 (Volume)
Fig Cancer & Tumor Therapy Market Forecast and CAGR 2018-2025 (Million USD)
Fig Cancer & Tumor Therapy Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Doxorubicin Market Size and CAGR 2011-2017 (Million USD)
Fig Liposomal Doxorubicin Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Doxorubicin Market Forecast and CAGR 2018-2025 (Million USD)
Fig Liposomal Doxorubicin Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Amphoteracin B Market Size and CAGR 2011-2017 (Million USD)
Fig Liposomal Amphoteracin B Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Million USD)
Fig Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Paclitaxel Market Size and CAGR 2011-2017 (Million USD)
Fig Liposomal Paclitaxel Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Million USD)
Fig Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Bupivacaine Market Size and CAGR 2011-2017 (Million USD)
Fig Liposomal Bupivacaine Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Bupivacaine Market Forecast and CAGR 2018-2025 (Million USD)
Fig Liposomal Bupivacaine Market Forecast and CAGR 2018-2025 (Volume)
Fig Other Liposomals Market Size and CAGR 2011-2017 (Million USD)
Fig Other Liposomals Market Size and CAGR 2011-2017 (Volume)
Fig Other Liposomals Market Forecast and CAGR 2018-2025 (Million USD)
Fig Other Liposomals Market Forecast and CAGR 2018-2025 (Volume)
Fig Other Liposomals Market Size and CAGR 2011-2017 (Million USD)
Fig Other Liposomals Market Size and CAGR 2011-2017 (Volume)
Fig Other Liposomals Market Forecast and CAGR 2018-2025 (Million USD)
Fig Other Liposomals Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Liposome Drug Delivery Market Size and CAGR 2011-2017 (Million USD)
Fig Global Liposome Drug Delivery Market Size and CAGR 2011-2017 (Volume)
Fig Global Liposome Drug Delivery Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Liposome Drug Delivery Market Forecast and CAGR 2018-2025 (Volume)
Fig Fungal Infection Therapy Market Size and CAGR 2011-2017 (Million USD)
Fig Fungal Infection Therapy Market Size and CAGR 2011-2017 (Volume)
Fig Fungal Infection Therapy Market Forecast and CAGR 2018-2025 (Million USD)
Fig Fungal Infection Therapy Market Forecast and CAGR 2018-2025 (Volume)
Fig Cancer & Tumor Therapy Market Size and CAGR 2011-2017 (Million USD)
Fig Cancer & Tumor Therapy Market Size and CAGR 2011-2017 (Volume)
Fig Cancer & Tumor Therapy Market Forecast and CAGR 2018-2025 (Million USD)
Fig Cancer & Tumor Therapy Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Doxorubicin Market Size and CAGR 2011-2017 (Million USD)
Fig Liposomal Doxorubicin Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Doxorubicin Market Forecast and CAGR 2018-2025 (Million USD)
Fig Liposomal Doxorubicin Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Amphoteracin B Market Size and CAGR 2011-2017 (Million USD)
Fig Liposomal Amphoteracin B Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Million USD)
Fig Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Paclitaxel Market Size and CAGR 2011-2017 (Million USD)
Fig Liposomal Paclitaxel Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Million USD)
Fig Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Bupivacaine Market Size and CAGR 2011-2017 (Million USD)
Fig Liposomal Bupivacaine Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Bupivacaine Market Forecast and CAGR 2018-2025 (Million USD)
Fig Liposomal Bupivacaine Market Forecast and CAGR 2018-2025 (Volume)
Fig Other Liposomals Market Size and CAGR 2011-2017 (Million USD)
Fig Other Liposomals Market Size and CAGR 2011-2017 (Volume)
Fig Other Liposomals Market Forecast and CAGR 2018-2025 (Million USD)
Fig Other Liposomals Market Forecast and CAGR 2018-2025 (Volume)
Fig Other Liposomals Market Size and CAGR 2011-2017 (Million USD)
Fig Other Liposomals Market Size and CAGR 2011-2017 (Volume)
Fig Other Liposomals Market Forecast and CAGR 2018-2025 (Million USD)
Fig Other Liposomals Market Forecast and CAGR 2018-2025 (Volume)
